Skip to medicine information
Protein Simülasyonları ve 3D Modelleme Medicine information · English summary

Evolocumab: Uses, Interactions and Safety

Uses

Evolocumab is a monoclonal antibody that binds PCSK9, allowing the liver to remove more LDL cholesterol from the blood. It is used with diet and appropriate lipid-lowering treatment for selected patients with high cholesterol, including familial disorders. Cardiovascular risk-reduction indications vary by country; the Turkish information includes established cardiovascular disease with background statin treatment.

Administration

It is injected under the skin using the prescribed pen, syringe or other authorised device. A clinician may teach a patient or caregiver to give it at home. Rotate injection sites and follow the instructions for that exact device. Keep scheduled injections and lipid tests; symptom relief is not a reliable measure of cholesterol control.

Safety

A serious allergic reaction is the main urgent safety concern. Facial, tongue or throat swelling, breathing difficulty or a widespread severe reaction needs emergency care. Some device needle covers contain a latex derivative, while others do not. Tell the team about latex allergy and check the supplied presentation rather than assuming all devices are identical.

Interactions

Evolocumab is commonly combined with a statin, and sometimes ezetimibe, to achieve additional LDL reduction. Statins can increase its clearance, but the observed lipid response is preserved and this does not require a statin dose change solely because evolocumab is added. Evidence for other combinations is more limited; lack of a typical CYP interaction is not a guarantee of safety for every treatment.

Pregnancy and breastfeeding

Pregnancy experience is limited. Use is generally reserved for a clinical need established by the treating team. It is unknown whether it enters human milk, so breastfeeding and treatment benefits must be assessed together.

Adverse effects

Injection-site reactions, upper respiratory symptoms, influenza-like illness, back pain and joint pain may occur. Persistent troublesome symptoms should be reviewed.

Sources

The linked Turkish profile contains the medicine record and its documented interaction list.

View the detailed profile and interaction list (Turkish)